Article
Cell‐free DNA screening and sex chromosome aneuploidies
19 Jun 2015
Abstract excerpt
Cell-free DNA (cfDNA) testing is increasingly being used to screen pregnant women for fetal aneuploidies. This technology may also identify fetal sex and can be used to screen for sex chromosome aneuploidies (SCAs). Physicians offering this screening will need to be prepared to offer comprehensive prenatal counseling about these disorders to an increasing number of patients. The purpose of this article is to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
